Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Suxibuzone

An anti-inflammatory analgesic, a prodrug of phenylbutazone described in the early 1970s: the body converts it into the active drug and it is used mainly in horses for joint and muscle pain. This family brings together the active ingredient.

Did you know?It is made by adding a hydroxymethyl group to phenylbutazone with formaldehyde and then a succinic acid "arm" with succinic anhydride, which is removed in the body.

SuxibuzoneGo to the active ingredient →
SuxibuzoneActive ingredientSuxibuzoneCat. No. P-S141-001CAS 27470-51-5

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Reference substanceSuxibuzone CRSEDQM code S2400000Family Suxibuzone

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.